Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06156254 · ClinicalTrials.gov registry record · NA
Community Care Intervention to Decrease COVID-19 Vaccination Inequities
A NA study of COVID-19 Vaccination, sponsored by RAND.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 4
- Study locations
NCT06156254: Recruiting NA study of COVID-19 Vaccination, sponsored by RAND.
NCT06156254 is a NA study of COVID-19 Vaccination that is actively recruiting participants, run by RAND. The registered enrollment target is 800 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06156254, a NA study of COVID-19 Vaccination, is actively recruiting participants, sponsored by RAND.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to find out if a community health workers (CHW) intervention conducted in Federally Qualified Health Centers (FQHCs) can increase the number of adults with chronic illnesses who are up-to-date with their COVID-19 and influenza vaccines.
Primary Outcome
COVID-19 vaccine acceptance at 3 months is measured by a survey self-report survey item asking participants to rate the following statement on a 5-to Likert scale (from 1 = strongly disagree to 5 = strongly agree): "If I was not up-to-date with the COVID-19 vaccines recommended for me, I would get the missing vaccinations." This variable is dichotomized to COVID-19 vaccine acceptance (0 = strongly disagree/disagree/neutral; 1 = agree/strongly agree)
Conditions Studied
Interventions
- BEHAVIORAL Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB)
Study Locations (4)
New York
- Brownsville Multi-Service Health Center - Brooklyn
- Bedford-Stuyvesant Family Health Center - Brooklyn
- Community Healthcare Network - New York
- Morris Heights Health Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT06156254 shows while recruiting
NCT06156254 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 1 condition, with COVID-19 Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB) is the first listed.
NCT06156254 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06156254 about?
NCT06156254 is a clinical study titled "Community Care Intervention to Decrease COVID-19 Vaccination Inequities". The purpose of this study is to find out if a community health workers (CHW) intervention conducted in Federally Qualified Health Centers (FQHCs) can increase the number of adults with chronic illnesses who are up-to-date with their COVID-19 and influenza vaccines.
What is the current status of trial NCT06156254?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2023-09-21. Estimated completion is 2026-06-01.
What conditions does trial NCT06156254 study?
This clinical trial studies the following conditions: COVID-19 Vaccination.
What interventions are being tested in trial NCT06156254?
The interventions under investigation include: Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06156254?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06156254 being conducted?
This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19 Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06156254's enrollment target sits among peer trials
800 135th of 2000 higher than 1,861 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI